PMV Pharmaceuticals News

Analysts Offer Insights on Healthcare Companies: PMV Pharmaceuticals (PMVP) and Phathom Pharmaceuticals (PHAT)

TipRanksMay 17 08:50 ET

PMV Pharmaceuticals Initiated at Buy by Craig-Hallum

PMV Pharmaceuticals Initiated at Buy by Craig-Hallum

Dow JonesMay 13 12:30 ET

Express News | Craig-Hallum Initiates Coverage On PMV Pharma With Buy Rating, Announces Price Target of $6

BenzingaMay 13 12:20 ET

Express News | PMV Pharma Q1 EPS $(0.30) Beats $(0.37) Estimate

BenzingaMay 9 08:52 ET

Express News | PMV Pharmaceuticals Inc: Ended Q1 With $213.1 Mln in Cash, Cash Equivalents, and Marketable Securities, Compared to $228.6 Mln as of December 31, 2023

ReutersMay 9 08:05 ET

PMV Pharmaceuticals | 10-Q: Quarterly report

Futu NewsMay 9 08:02 ET · Announcements

Express News | PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights

ReutersMay 9 08:00 ET

PMV Pharmaceuticals 1Q Loss/Shr 30c >PMVP

PMV Pharmaceuticals 1Q Loss/Shr 30c >PMVP

Dow JonesMay 9 08:00 ET

PMV Pharmaceuticals Initiated at Buy by Jefferies

PMV Pharmaceuticals Initiated at Buy by Jefferies

Dow JonesApr 12 09:31 ET

Jefferies Starts PMV Pharmaceuticals With Buy Rating, $5 Price Target

Jefferies Starts PMV Pharmaceuticals With Buy Rating, $5 Price Target.

MT NewswiresApr 12 08:03 ET

Express News | PMV Pharmaceuticals Inc : Jefferies Initiates Coverage With Buy Rating; Target Price $5

Moomoo 24/7Apr 12 00:41 ET

PMV Pharmaceuticals Doses First Patient In Global Tumor-Agnostic Phase 2 PYNNACLE Trial For Rezatapopt In TP53 Y220C-Positive Solid Tumors

PMV Pharmaceuticals Doses First Patient In Global Tumor-Agnostic Phase 2 PYNNACLE Trial For Rezatapopt In TP53 Y220C-Positive Solid Tumors

BenzingaMar 27 08:10 ET

Oppenheimer Remains a Hold on PMV Pharmaceuticals (PMVP)

TipRanksMar 19 07:55 ET

PMV Pharmaceuticals PYNNACLE Phase I Data Of Rezatapopt In Advanced Ovarian Cancer Featured In Oral Presentation At 2024 SGO Annual Meeting On Women's Cancer

Phase 1 analysis from the PYNNACLE Phase 1/2 study showed promising efficacy of rezatapopt (PC14586) in heavily pre-treated patients with advanced ovarian cancer harboring a TP53 Y220C mutation featur

BenzingaMar 18 16:02 ET

Big Pharma Patent Cliffs Seen Fueling Oncology M&A This Year

Seeking AlphaMar 10 13:08 ET

Express News | HC Wainwright & Co. Reiterates Buy on PMV Pharma, Maintains $5 Price Target

Moomoo 24/7Mar 7 07:11 ET

PMV Pharmaceuticals: Buy Rating Affirmed Amid Strong Financials and Promising Clinical Prospects

TipRanksMar 7 06:27 ET

Express News | PMV Pharmaceuticals Shares Are Trading Higher After the Company Reported a Year-over-year Increase in FY23 EPS Results

Moomoo 24/7Mar 1 11:17 ET

PMV Pharmaceuticals Inc (PMVP) Reports Full Year 2023 Financial Results

Yahoo FinanceMar 1 10:21 ET

Oppenheimer Keeps Their Hold Rating on PMV Pharmaceuticals (PMVP)

TipRanksMar 1 07:48 ET